Cohort Studyhigh evidence
Mapping the effectiveness and risks of GLP-1 receptor agonists.
Nature medicine·March 1, 2025·PMID 39833406
Why it mattersPain specialists managing patients with diabetes and obesity need to understand the wide-ranging effects of GLP-1RAs, including potential neuropsychiatric and inflammatory benefits, as well as gastrointestinal and renal risks that may influence pain management strategies.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled